Evidence map›Paper›PMID 30034684›Full record

ArticleChemical science2016

DNA-mediated cell surface engineering for multiplexed glycan profiling using MALDI-TOF mass spectrometry.

Ziyi He, Qiushui Chen, Fengming Chen, Jie Zhang, Haifang Li, Jin-Ming Lin

Abstract read
In one paragraph

Article in Chemical science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Proteomic Distributions in CD34+ Microvascular Niche Patterns of Glioblastoma.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  10. Article
  11. Laser cleavable probes forChemical science · 2019
    Article
  12. Article
  13. Article
  14. Bifunctional cleavable probes forChemical science · 2019
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ziyi HeDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.ORCID 0000-0002-9817-4791
Qiushui ChenDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.
Fengming ChenDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.
Jie ZhangDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.
Haifang LiDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.
Jin-Ming LinDepartment of Chemistry , Beijing Key Laboratory of Microanalytical Methods and Instrumentation , Tsinghua University , Beijing 100084 , China . Email: jmlin@tsinghua.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycans are crucial for many key biological processes and their alterations are often a hallmark of disease. Thus, multiplexed and sensitive analysis of glycans is of intense interest. Here we report a novel approach using DNA-mediated cell surface engineering for glycan profiling by MALDI-TOF mass spectrometry (MS). Following lectin binding, DNA amplification and hybridization, glycans on the cell surface are specifically labeled by short DNA probes, which can be facilely released, ionized and detected in MALDI-TOF MS. This strategy converts the analysis of glycans to the detection of DNA probes, overcoming the complicated composition and low ionization efficiency of glycans, enabling

Identifiers

PMID30034684
PMCPMC6021752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.